Page 23 - AN-3-3

Advanced Neurology Alzheimer’s and Parkinson’s disease rodent models

80. De Strooper B, Iwatsubo T, Wolfe MS. Presenilins and doi: 10.1186/s13195-023-01175-z
γ-secretase: Structure, function, and role in Alzheimer 90. Ben-Nejma IRH, Keliris AJ, Daans J, et al. Increased
disease. Cold Spring Harb Perspect Med. 2012;2(1):a006304.
soluble amyloid-beta causes early aberrant brain network
doi: 10.1101/cshperspect.a006304 hypersynchronisation in a mature-onset mouse model of
81. Radde R, Bolmont T, Kaeser SA, et al. Aβ42‐driven cerebral amyloidosis. Acta Neuropathol Commun. 2019;7(1):180.
amyloidosis in transgenic mice reveals early and robust doi: 10.1186/s40478-019-0810-7
pathology. EMBO Rep. 2006;7(9):940-946.
91. Tomiyama T, Matsuyama S, Iso H, et al. A mouse
doi: 10.1038/sj.embor.7400784 model of amyloid beta oligomers: Their contribution
82. Richard BC, Kurdakova A, Baches S, Bayer TA, to synaptic alteration, abnormal tau phosphorylation,
Weggen S, Wirths O. Gene dosage dependent aggravation of glial activation, and neuronal loss in vivo. J Neurosci.
the neurological phenotype in the 5×FAD mouse model of 2010;30(14):4845-4856.
Alzheimer’s disease. J Alzheimers Dis. 2015;45(4):1223-1236. doi: 10.1523/JNEUROSCI.5825-09.2010
doi: 10.3233/JAD-143120 92. Oddo S, Caccamo A, Shepherd JD, et al. Triple-transgenic
83. Giannoni P, Arango-Lievano M, Neves ID, et al. model of Alzheimer’s disease with plaques and tangles:
Cerebrovascular pathology during the progression Intracellular Abeta and synaptic dysfunction. Neuron.
of experimental Alzheimer’s disease. Neurobiol Dis. 2003;39(3):409-421.
2016;88:107-117. doi: 10.1016/s0896-6273(03)00434-3
doi: 10.1016/j.nbd.2016.01.001
93. Guo Q, Fu W, Sopher BL, et al. Increased vulnerability of
84. Oblak AL, Lin PB, Kotredes KP, et al. Comprehensive hippocampal neurons to excitotoxic necrosis in presenilin-1
evaluation of the 5×FAD mouse model for preclinical testing mutant knock-in mice. Nat Med. 1999;5(1):101-106.
applications: A MODEL-AD study. Front Aging Neurosci.
2021;13:713726. doi: 10.1038/4789
94. Stover KR, Campbell MA, Van Winssen CM, Brown RE. Early
doi: 10.3389/fnagi.2021.713726
detection of cognitive deficits in the 3×Tg-AD mouse model
85. Jawhar S, Trawicka A, Jenneckens C, Bayer TA, Wirths O. of Alzheimer’s disease. Behav Brain Res. 2015;289:29-38.
Motor deficits, neuron loss, and reduced anxiety coinciding
with axonal degeneration and intraneuronal Aβ aggregation doi: 10.1016/j.bbr.2015.04.012
in the 5×FAD mouse model of Alzheimer’s disease. Neurobiol 95. Saito T, Matsuba Y, Mihira N, et al. Single App knock-in
Aging. 2012;33(1):196.e29-e40. mouse models of Alzheimer’s disease. Nat Neurosci.
doi: 10.1016/j.neurobiolaging.2010.05.027 2014;17(5):661-663.
86. Mucke L, Masliah E, Yu GQ, et al. High-level neuronal doi: 10.1038/nn.3697
expression of abeta 1-42 in wild-type human amyloid 96. Nilsson P, Saito T, Saido TC. New mouse model of
protein precursor transgenic mice: Synaptotoxicity without Alzheimer’s. ACS Chem Neurosci. 2014;5(7):499-502.
plaque formation. J Neurosci. 2000;20(11):4050-4058.
doi: 10.1021/cn500105p
doi: 10.1523/JNEUROSCI.20-11-04050.2000
97. Latif-Hernandez A, Sabanov V, Ahmed T, et al. The two
87. Wright AL, Zinn R, Hohensinn B, et al. Neuroinflammation faces of synaptic failure in AppNL-G-F knock-in mice.
and neuronal loss precede Aβ plaque deposition in the Alzheimers Res Ther. 2020;12(1):100.
hAPP-J20 mouse model of Alzheimer’s disease. PLoS One.
2013;8(4):e59586. doi: 10.1186/s13195-020-00667-6
doi: 10.1371/journal.pone.0059586 98. Foley KE, Hewes AA, Garceau DT, et al. The APOE ε3/ε4
genotype drives distinct Gene signatures in the cortex of
88. Jankowsky JL, Slunt HH, Gonzales V, et al. Persistent young mice. Front Aging Neurosci. 2022;14:838436.
amyloidosis following suppression of Abeta production
in a transgenic model of Alzheimer disease. PLoS Med. doi: 10.3389/fnagi.2022.838436
2005;2(12):e355. 99. McLean JW, Bhattrai A, Vitali F, Raikes AC, Wiegand JPL,
doi: 10.1371/journal.pmed.0020355 Brinton RD. Contributions of sex and genotype to
exploratory behavior differences in an aged humanized
89. Ben-Nejma IRH, Keliris AJ, Vanreusel V, Ponsaerts P, Van
der Linden A, Keliris GA. Altered dynamics of glymphatic APOE mouse model of late-onset Alzheimer’s disease. Learn
flow in a mature-onset Tet-off APP mouse model of Mem. 2022;29(9):321-331.
amyloidosis. Alzheimers Res Ther. 2023;15(1):23. doi: 10.1101/lm.053588.122

Volume 3 Issue 3 (2024) 17 doi: 10.36922/an.2903